PIM
GSK icon

Provident Investment Management’s GSK GSK Stock Holding History

Provident Investment Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-21,750
Closed -$843K – 77
2025
Q1 		$843K Buy
21,750
+75
+0.3% +$2.75K 0.08% 47
2024
Q4 		$733K Buy
21,675
+3,100
+17% +$112K 0.07% 51
2024
Q3 		$759K Buy
18,575
+905
+5% +$37K 0.07% 48
2024
Q2 		$680K Buy
17,670
+11,150
+171% +$469K 0.06% 53
2024
Q1 		$280K Buy
+6,520
New +$269K 0.02% 67

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Provident Investment Management's GSK Position: Q2 2025 in Review

Provident Investment Management sold out of GSK (GSK) in Q2 2025, closing a stake of 21,750 shares — an estimated $843K sold.

Provident Investment Management first reported a position in GSK in Q1 2024 and held it in 5 quarters. The position peaked at $843K in Q1 2025. 890 funds tracked by Wall St. Rank hold GSK as of Q2 2025.

  • Provident Investment Management reported no remaining GSK position as of Q2 2025 after selling out during the quarter.
  • Provident Investment Management sold 21,750 GSK shares in Q2 2025, an estimated $843K.
  • Provident Investment Management first reported a position in GSK in Q1 2024 and held it in 5 quarters.
  • Provident Investment Management's GSK position peaked at $843K in Q1 2025.
  • 890 funds tracked by Wall St. Rank held GSK as of Q2 2025.

Based on Provident Investment Management's 13F filing for Q2 2025, filed 26 Aug 2025.